Clinical Trial Update: Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the effect of inhaled fluticasone furoate on short-term growth in pediatric asthma subjects; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Arnuity Ellipta (Fluticasone furoate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2016-07-29